glp 1 agonists reduce inflammation GLP-1 receptor show evidence of reducing #Psoriasis severity and systemic in patients with #obesity or #diabetes, with a favorable safety profile and compatibility with standard therapies. https://t.co/aMBllABaVT Central glucagon-like peptide 1 receptor

Why Muscle Maintenance Matters During Weight Loss Weight loss often leads to a decrease in both fat and lean muscle mass

A 2022 study on Ozempic found that most individuals regain the weight, and more, within a year after stopping the medication

What happened to me was not what I expected

This is why copper peptides (specifically AHK-Cu and its close relative GHK-Cu) are now considered one of the most promising non-pharmaceutical approaches to hair loss

Rare-variant association analysis: study designs and statistical tests

Pulm Pharmacol Ther 20:922, PMID: 16458553 Cotgreave IA (1997) N -acetylcysteine: pharmacological considerations and experimental and clinical applications